Yanhong Chen

Yanhong Chen


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2023 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
YJYan Jiao
Yan Jiao
YLYan Liu
Yan Liu
HLHongyuan Li
Hongyuan Li
ZSZimeng Song
Zimeng Song
SWShiliang Wang
Shiliang Wang
YCYanhong Chen
Yanhong Chen
Background: HELLP syndrome refers to a group of clinical syndromes characterized by hemolysis, elevated liver enzymes and low platelet, and the evidence on the association between proteinuria and the severity of HELLP and its maternal and neonatal outcomes is rare. Methods: 106 pregnant women were assigned to the proteinuric group (24-hUPro ≥ 0.3 g, 79 cases) and the non-proteinuric group (24-hUPro < 0.3 g, 27 cases). The proteinuric group was further divided into three subgroups: mild group (24-hUPro:0.3-2.0 g, 33 cases), moderate group (24-hUPro:2.0-5.0 g, 21 cases) and severe group (24-hUPro: ≥5.0 g, 25 cases). The general clinical data, laboratory indexes, complications and pregnancy outcome and adverse neonatal outcomes of HELLP with or without proteinuric were analyzed. Results: Compared with proteinuric group, the non-albuminuric group or in the three proteinuric subgroups of HELLP pregnant women’s, increased proteinuria was associated with earlier onset gestations, higher incidence of abdominal pain, skin jaundice, headache, blurred vision (p < 0.05 respectively), and also the higher levels of ALT, AST, LDH, Fib, APTT, ATII, proportions of tubular urine and lower levels of ALB, PLT (p < 0.05 respectively). In the three subgroups of the proteinuric group, the ratio of fetal growth restriction, cesarean section and postpartum hemorrhage were compared, and the difference was statistically significant (p < 0.05 respectively). Compared with the proteinuric group, the non-proteinuric group had higher birth weight, birth length, and lower SGA, admission rate in NICU (p < 0.05 respectively). In the three subgroups of the proteinuric group, significant differences were identified in the adverse outcomes of newborns (p < 0.05 respectively), and the incidence of adverse outcomes in neonates tended to be higher. Significant differences were identified in birth weight, birth length, and lower SGA and NICU occupancy rate among the three subgroups (p < 0.05 respectively). Conclusions: HELLP syndrome is a severe complication of pregnancy, involving multiple systems of the whole body. It has posed a great challenge to obstetricians for its acute onset, dangerous condition, rapid progress, and great harm. Thus, insights into HELLP syndrome should be gained, and early diagnosis, early treatment and timely termination of pregnancy should be conducted to reduce the incidence of maternal and fetal adverse outcomes and improve maternal and fetal prognosis.

27 October 2026 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
XHXincheng Hu
Xincheng Hu
YZYuerong Zou
Yuerong Zou
KTKanagaraj Thangamani
Kanagaraj Thangamani
RKRangasamy Kayalvizhi
Rangasamy Kayalvizhi
AAArivazhagan Anandhan
Arivazhagan Anandhan
YCYanhong Chen
Yanhong Chen
Meropenem (MP) is an important carbapenem antibiotic used as a last-line treatment that requires precise quantification for therapeutic drug monitoring and environmental antibiotic surveillance. Herein, nitrogen, sulfur co-doped carbon dots (N,S-CDs) were derived from L-tryptophan and thiourea for MP detection. The prepared N,S-CDs were characterized by using UV–VIS, X-ray diffraction (XRD), Fourier transform infrared (FT-IR) spectroscopy, high-resolution transmission electron microscopy (HR-TEM), and fluorescence spectroscopy. The interaction with MP led to systematic quenching of fluorescence (λ em = 457 nm, λ ex = 350 nm), a Stern–Volmer constant Ksv = 3.97 × 10 6 M −1 , a binding constant Ka = 9.07 × 10 6 M −1 , and a decrease in the fluorescence lifetime from 6.45 to 5.68 ns. A linear response was exhibited throughout the 0–390 nM range (R 2 = 0.990) with a limit of detection (LOD) of 6.8 nM. The sensor demonstrated high selectivity toward MP with a 1250-fold excess of coexisting inorganic ions, biomolecules, and structurally related carbapenem antibiotics. Intracellular fluorescence imaging and concentration-dependent intracellular MP detection were also demonstrated in live PC3 cells with negligible cytotoxicity (cell viability > 80% up to 10 mg/mL), indicating its potential for clinical therapeutic drug monitoring and environmental surveillance. The probe was successfully validated for the analysis of MP in pharmaceutical formulations, human serum, urine, and environmental water samples, with recoveries (%) in the range of 98%–102%. This work presents N,S-CDs as a robust, sensitive, and biocompatible analytical tool for clinical, pharmacological, and environmental MP surveillance.

26 December 2025 in BMC Immunology
Verified
Journal Article
Open access
PDF file
BZBeibei Zu
Beibei Zu
YFYu Fu
Yu Fu
FGFeng Gu
Feng Gu
PWPeng Wang
Peng Wang
SWShixing Wang
Shixing Wang
YCYanhong Chen
Yanhong Chen
Laboratory diagnostic markers and clinical presentations of Sjögren’s disease (SjD) may vary by sex. This study aimed to investigate the associa

16 January 2023 in Research Square
Verified
Preprint
Open access
PDF file
YJYan Jiao
Yan Jiao
ZSZimeng Song
Zimeng Song
HLHongyuan Li
Hongyuan Li
SWShiliang Wang
Shiliang Wang
JZJiao Zhang
Jiao Zhang
YCYanhong Chen
Yanhong Chen
Background: HELLP syndrome refers to a group of clinical syndromes characterized by hemolysis, elevated liver enzymes and low platelet, and the evidence on the association between proteinuria and the severity of HELLP and its maternal and neonatal outcomes is rare. Methods: 106 pregnant women were assigned to the proteinuric group (24-hUPro ≥0.3 g, 79 cases) and the non-proteinuric group (24-hUPro<0.3 g, 27 cases). The proteinuric group was further divided into three subgroups: mild group (24-hUPro:0.3-2.0g, 33 cases), moderate group (24-hUPro:2.0-5.0g, 21 cases) and severe group (24-hUPro: ≥5.0 g, 25 cases). The general clinical data, laboratory indexes, complications and pregnancy outcome and adverse neonatal outcomes of HELLP with or without proteinuric were analyzed. Results: Compared with proteinuricgroup, the non-albuminuric group or in the three proteinuric subgroups of HELLP pregnant women's , increased proteinuria was associated with earlier onset gestations, higher incidence of abdominal pain, skin jaundice, headache, blurred vision (p < 0.05 respectively), and also the higher levels of ALT, AST, LDH, Fib, APTT, ATⅢ, proportions of tubular urine and lower levels of ALB, PLT (p< 0.05 respectively). In the three subgroups of the proteinuric group, the ratio of fetal growth restriction, cesarean section and postpartum hemorrhage were compared, and the difference was statistically significant (p < 0.05 respectively). Compared with the proteinuric group, the non-proteinuric group had higher birth weight, birth length, and lower SGA, admission rate in NICU (p < 0.05 respectively). In the three subgroups of the proteinuric group, significant differences were identified in the adverse outcomes of newborns (p < 0.05 respectively), and the incidence of adverse outcomes in neonates tended to be higher. Significant differences were identified in birth weight, birth length, and lower SGA and NICU occupancy rate among the three subgroups (p < 0.05 respectively). Conclusions: HELLP syndrome is a severe complication of pregnancy, involving multiple systems of the whole body. It has posed a great challenge to obstetricians for its acute onset, dangerous condition, rapid progress, and great harm. Thus, insights into HELLP syndrome should be gained, and early diagnosis, early treatment and timely termination of pregnancy should be conducted to reduce the incidence of maternal and fetal adverse outcomes and improve maternal and fetal prognosis.